Showing 6311-6320 of 19376 results for "".
Cortical Stimulation For Stroke Recovery
https://reachmd.com/programs/clinicians-roundtable/cortical-stimulation-for-stroke-recovery/1128/Cortical Stimulation has been found to improve the brain functioning of patients after stroke. In this segment Dr. Richard Harvey of RIC explains 3 methods of cortical stimulation and talks about when, how and why cortical stimulation can improve outcomes for stroke patients.Plastic Surgery: Facial and Body Contouring
https://reachmd.com/programs/clinicians-roundtable/plastic-surgery-facial-and-body-contouring/9/Dr. Tijunelis identifies the concerns, new advances and expectations of plastic surgery for facial and body contouring.Updates in MS Care: Key Topics at AAN 2026
https://reachmd.com/programs/neurofrontiers/aan-2026-key-topics-ms/54248/Hear from Dr. Aaron Miller as he shares important updates in multiple sclerosis (MS) at the 2026 American Academy of Neurology (AAN) Annual Meeting. Dr. Miller is the Medical Director of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis and a Professor of Neurology at the Icahn SBoosting Colorectal Cancer Re-Screening: The Role of Spanish Language Navigation
https://reachmd.com/programs/clinicians-roundtable/boosting-colorectal-cancer-re-screening-the-role-of-spanish-language-navigation/36539/A recent study showed that tailored Spanish-language navigation paired with the multi-target stool DNA (mt-sDNA) test can significantly improve colorectal cancer re-screening adherence among Spanish-speaking patients. Hear Ryan Quigley speak with Dr. Mallik Greene, a coauthor of the study, about howOperational Considerations for Bispecific T-Cell Engager Therapies
https://reachmd.com/programs/medical-industry-feature/operational-considerations-for-bispecific-t-cell-engager-therapies/33005/In recent years, bispecific T-cell engager therapies have emerged as an innovative approach for treating cancer by directing the patient’s own T-cells to target tumor‑associated antigens on cancer cells.1 However, the implementation of bispecific T-cell engager therapies into clinical practice comeGrowth Recovery After Tovorafenib in Pediatric Low-Grade Gliomas: New Data
https://reachmd.com/programs/project-oncology/growth-recovery-after-tovorafenib-in-pediatric-low-grade-gliomas/37196/As tovorafenib use expands in children with BRAF-altered low-grade gliomas, new data offer critical insight into one of its key safety considerations: growth suppression. Based on post hoc findings from multiple studies, most patients who experienced growth suppression during treatment demonstratedThe Belly and the Brain: Weight Management and Headache
https://reachmd.com/diseases-diagnoses/headache-pain/the-belly-and-the-brain-weight-management-and-headache/39225/Jennifer Williams McVige, MD, Director of the DENT Concussion Institute and Attending Neurologist at the DENT Neurologic Institute, Buffalo, NY, discusses the clinical evidence linking weight management with the improvement of headache symptoms and outlines practical strategies—including diet and exPrednisone and Lupus – A Treatment Mainstay?
https://reachmd.com/programs/conference-coverage/prednisone-and-lupus-a-treatment-mainstay/10300/What’s the link between lupus and vitamin D levels? Get exclusive insights into a top thought leader’s research on key management strategies.Toxic Short RNAs May Cause Neuronal Cell Death in Alzheimer’s Disease
https://reachmd.com/programs/neurofrontiers/toxic-short-rnas-may-cause-neuronal-cell-death-in-alzheimers-disease/17829/Dive into a study that investigated how toxic short RNAs may lead to neuronal cell death in Alzheimer's disease.Debunking Myopia Myths: Kids Are Safer Contact Lens Wearers Than You May Think
https://reachmd.com/programs/eye-on-ocular-health/debunking-myopia-myths-kids-are-safer-contact-lens-wearers-than-you-may-think/36283/Many parents hesitate to allow young children to wear contact lenses, fearing poor hygiene or increased risk of infection. But evidence shows that kids between the ages of 7 and 12 are not at higher risk than teens; in fact, they actually have fewer complications than college-age wearers, and long-t